Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-18

Clinical Trial Update: Personalized TACS to Reduce Rumination in Patients with Active Suicidal Ideation [NA]

View source ↗

Summary

A clinical trial is investigating personalized transcranial alternating current stimulation (TACS) to reduce rumination in patients with active suicidal ideatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sebastian Olbrich | Conditions: Suicidal Ideation Active, Depression Disorders | NA | Status: NOT_YET_RECRUITING